In the complex world of healthcare finance, trust and transparency between payers and providers are often elusive. But for one Arizona-based integrated delivery network (IDN), partnering with Zelis—a ...

A study has found that adults with obesity taking GLP-1 receptor agonists may face significantly lower risk of developing certain cancers. The cohort study was led by researchers from the Indiana ...

The FDA has accepted Stealth BioTherapeutics’ resubmission of its new drug application for elamipretide, a treatment for Barth syndrome. The agency set an earlier review target date of Sept. 26, ahead ...

Summer of 2025 was an unusual one for health system leaders across the country that, in many ways, seemed to move both slowly and abruptly at once. Here are seven of the many questions that health ...